ASTEC Stock Overview
Engages in the manufacture and sale of agrochemical active ingredients and pharmaceutical intermediates in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Astec LifeSciences Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,083.00 |
| 52 Week High | ₹1,474.40 |
| 52 Week Low | ₹825.05 |
| Beta | 0.28 |
| 11 Month Change | -12.22% |
| 3 Month Change | -15.85% |
| 1 Year Change | -14.64% |
| 33 Year Change | -12.26% |
| 5 Year Change | 198.10% |
| Change since IPO | 1,189.29% |
Recent News & Updates
Recent updates
Shareholders May Be Wary Of Increasing Astec LifeSciences Limited's (NSE:ASTEC) CEO Compensation Package
Jul 23
Market Participants Recognise Astec LifeSciences Limited's (NSE:ASTEC) Revenues Pushing Shares 28% Higher
Jul 03Astec LifeSciences Limited (NSE:ASTEC) Stocks Shoot Up 30% But Its P/S Still Looks Reasonable
Mar 15Astec LifeSciences (NSE:ASTEC) Could Be Struggling To Allocate Capital
May 17Shareholders Are Optimistic That Astec LifeSciences (NSE:ASTEC) Will Multiply In Value
Oct 14We Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Jul 27Here's Why Astec LifeSciences (NSE:ASTEC) Can Manage Its Debt Responsibly
Jun 28A Look At The Intrinsic Value Of Astec LifeSciences Limited (NSE:ASTEC)
Jun 03Analysts Just Published A Bright New Outlook For Astec LifeSciences Limited's (NSE:ASTEC)
May 08Astec LifeSciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 06Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 25Is Astec LifeSciences (NSE:ASTEC) A Risky Investment?
Dec 13We Take A Look At Why Astec LifeSciences Limited's (NSE:ASTEC) CEO Has Earned Their Pay Packet
Jul 21Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
May 02The Trend Of High Returns At Astec LifeSciences (NSE:ASTEC) Has Us Very Interested
Apr 17Do Astec LifeSciences's (NSE:ASTEC) Earnings Warrant Your Attention?
Apr 02Is Astec LifeSciences Limited's (NSE:ASTEC) Shareholder Ownership Skewed Towards Insiders?
Mar 18Have Insiders Been Selling Astec LifeSciences Limited (NSE:ASTEC) Shares?
Mar 05Did You Miss Astec LifeSciences' (NSE:ASTEC) Whopping 481% Share Price Gain?
Feb 20A Look At Astec LifeSciences' (NSE:ASTEC) CEO Remuneration
Feb 08Declining Stock and Solid Fundamentals: Is The Market Wrong About Astec LifeSciences Limited (NSE:ASTEC)?
Jan 28What Does Astec LifeSciences Limited's (NSE:ASTEC) Share Price Indicate?
Jan 17
Why We Like The Returns At Astec LifeSciences (NSE:ASTEC)
Jan 08I Ran A Stock Scan For Earnings Growth And Astec LifeSciences (NSE:ASTEC) Passed With Ease
Dec 28Is Astec LifeSciences Limited (NSE:ASTEC) Popular Amongst Insiders?
Dec 18Astec LifeSciences (NSE:ASTEC) Is Growing Earnings But Are They A Good Guide?
Dec 07Does Astec LifeSciences (NSE:ASTEC) Have A Healthy Balance Sheet?
Nov 27Shareholder Returns
| ASTEC | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -0.9% | -0.6% | -0.9% |
| 1Y | -14.6% | 23.4% | 39.7% |
Return vs Industry: ASTEC underperformed the Indian Chemicals industry which returned 23.4% over the past year.
Return vs Market: ASTEC underperformed the Indian Market which returned 39.7% over the past year.
Price Volatility
| ASTEC volatility | |
|---|---|
| ASTEC Average Weekly Movement | 4.8% |
| Chemicals Industry Average Movement | 5.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 3.9% |
Stable Share Price: ASTEC has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: ASTEC's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 606 | Anurag Roy | www.godrejastec.com |
Astec LifeSciences Limited, together with its subsidiaries, engages in the manufacture and sale of agrochemical active ingredients and pharmaceutical intermediates in India. It offers triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. The company also provides herbicides, insecticides, and specialty chemical products.
Astec LifeSciences Limited Fundamentals Summary
| ASTEC fundamental statistics | |
|---|---|
| Market cap | ₹21.24b |
| Earnings (TTM) | -₹784.59m |
| Revenue (TTM) | ₹3.85b |
5.5x
P/S Ratio-27.1x
P/E RatioIs ASTEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASTEC income statement (TTM) | |
|---|---|
| Revenue | ₹3.85b |
| Cost of Revenue | ₹3.04b |
| Gross Profit | ₹813.05m |
| Other Expenses | ₹1.60b |
| Earnings | -₹784.59m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 25, 2024
| Earnings per share (EPS) | -40.01 |
| Gross Margin | 21.11% |
| Net Profit Margin | -20.37% |
| Debt/Equity Ratio | 133.7% |
How did ASTEC perform over the long term?
See historical performance and comparison